Evidence map›Paper›PMID 24055910›Full record

ArticleCellular signalling2014

The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.

Ji Hee Ha, Jeremy D Ward, Lakshmi Varadarajalu, Sang Geon Kim, Danny N Dhanasekaran

Open access · greenAbstract read
In one paragraph

Article in Cellular signalling, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Gα13 Stimulates the Tyrosine Phosphorylation of Ric-8A.Journal of molecular signaling · 2015
    Article
  9. Expressions of lysophosphatidic acid receptors in the development of human ovarian carcinoma.International journal of clinical and experimental medicine · 2015
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ji Hee HaPeggy and Charles Stephenson Cancer Center, The University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC West 1468, Oklahoma City, OK 73104, United States; College of Pharmacy, Seoul National University, Seoul, South Korea; Department of Cell Biology, The University of Oklahoma Health Sciences Center, 975 NE 10th Street, BRC West 1468, Oklahoma City, OK 73104, United States.
Jeremy D Ward
Lakshmi Varadarajalu
Sang Geon Kim
Danny N Dhanasekaran
Seoul National University · KRUniversity of Oklahoma Health Sciences Center · US

Funding

TUMOR RESISTANCE MECHANISMS TO ANTI-VEGF THERAPY IN PROSTATE CANCER (Sukyung Woo)P20GM103639 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI HANNAFON, BETHANY · 2012 to 2022
$21.3M
G Proteins and Their Receptors in Tumor Cell MetastasisR01CA116984 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2007 to 2011
$1.5M
Regulation of JNK-signaling molecules by the gep oncogenesR01CA123233 · NCI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI DHANASEKARAN, DANNY N. · 2008 to 2013
$1.3M
G ALPHA 12/G ALPHA 13 G PROTEINSR01GM049897 · NIGMS · TEMPLE UNIVERSITY · PI DHANASEKARAN, DANNY N. · 1996 to 2004
$1.1M
NCI NIH HHS CA116984NCI NIH HHS CA123233NCI NIH HHS R01 CA116984NCI NIH HHS R01 CA123233NIGMS NIH HHS P20 GM103639NIGMS NIH HHS R01 GM049897
6 · The paper itself

Abstract

Lysophosphatidic acid (LPA) plays a critical role in the pathophysiology of ovarian cancers. Previous studies have shown that LPA stimulates the proliferation of ovarian cancer cells via Gα12. The present study utilizing Protein/DNA array analyses of LPA-stimulated HeyA8 cells in which the expression of Gα12 was silenced, demonstrates for the first time that Gα12-dependent mitogenic signaling by LPA involves the atypical activation cAMP-response element binding protein (CREB). Results indicate that the robust activation of CREB by LPA is an early event that can be monitored by the phosphorylation of SER133 of CREB as early as 3min. The findings that the expression of the constitutively activated mutant of Gα12 stimulates CREB even in the absence of LPA in multiple ovarian cancer cell lines confirm the direct role of Gα12 in the activation of CREB. This is further substantiated by the observation that the silencing of Gα12 drastically attenuates LPA-stimulated phosphorylation of CREB. Our results also establish that LPA-Gα12-dependent activation of CREB is through a cAMP-independent, but Ras-ERK-dependent mechanism. More significantly, our findings indicate that the expression of the dominant negative S133A mutant of CREB leads to a reduction in LPA-stimulated proliferation of HeyA8 ovarian cancer cells. Thus, results presented here demonstrate for the first time that CREB is a critical signaling node in LPA-LPAR and Gα12/gep proto-oncogene stimulated oncogenic signaling in ovarian cancer cells.

Indexed as

Cell Line, TumorCell ProliferationCyclic AMPCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesFemaleGTP-Binding Protein alpha Subunits, G12-G13HumansLysophospholipidsModels, BiologicalMutant ProteinsOvarian NeoplasmsPhosphorylationPhosphoserineProto-Oncogene Masras ProteinsCyclic AMPCyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesGTP-Binding Protein alpha Subunits, G12-G13lysophosphatidic acidLysophospholipidsMAS1 protein, humanMutant ProteinsPhosphoserineProto-Oncogene Masras ProteinsTranscription FactorsCREBCyclic-AMP Response Element Binding ProteinERKExtracellular-signal Regulated KinaseGα(12)LPALPARLPA-receptorLysophosphatidic AcidMitogen and Stress-activated protein Kinase-1MSK1OncogeneOvarian cancerp38MAPKp38-Mitogen-activated Protein Kinase

Identifiers

PMID24055910
PMCPMC3992271
OpenAlexW2086482805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.